139 related articles for article (PubMed ID: 9191178)
1. Heterogeneity and immunotherapy of specific T-cells in myasthenia gravis.
Bond A; Corlett L; Nagvekar N; Jacobson L; Pantic N; Beeson D; Nicolle M; Vincent A; Newsom-Davis J; Spack E; Willcox N
Biochem Soc Trans; 1997 May; 25(2):665-70. PubMed ID: 9191178
[No Abstract] [Full Text] [Related]
2. Antibodies to acetylcholine receptor in patients with thymoma but without myasthenia gravis.
Cuénoud S; Feltkamp TE; Fulpius BW; Oosterhuis HJ
Neurology; 1980 Feb; 30(2):201-2. PubMed ID: 7188802
[TBL] [Abstract][Full Text] [Related]
3. Thymus, thymoma, and specific T cells in myasthenia gravis.
Beeson D; Bond AP; Corlett L; Curnow SJ; Hill ME; Jacobson LW; MacLennan C; Meager A; Moody AM; Moss P; Nagvekar N; Newsom-Davis J; Pantic N; Roxanis I; Spack EG; Vincent A; Willcox N
Ann N Y Acad Sci; 1998 May; 841():371-87. PubMed ID: 9668262
[No Abstract] [Full Text] [Related]
4. Thymus, thymoma and myasthenia gravis.
Fujii Y
Surg Today; 2013 May; 43(5):461-6. PubMed ID: 22948665
[TBL] [Abstract][Full Text] [Related]
5. Editorial: Cause of weakness in myasthenia gravis.
Grob D
N Engl J Med; 1976 Mar; 294(13):722-3. PubMed ID: 1082544
[No Abstract] [Full Text] [Related]
6. Myasthenia gravis.
Willcox N
Curr Opin Immunol; 1993 Dec; 5(6):910-7. PubMed ID: 8297524
[TBL] [Abstract][Full Text] [Related]
7. Anti-acetylcholine receptor antibody synthesis by cultured lymphocytes in myasthenia gravis: thymic and peripheral blood cell interactions.
Newsom-Davis J; Willcox N; Scadding G; Calder L; Vincent A
Ann N Y Acad Sci; 1981; 377():393-402. PubMed ID: 6978662
[No Abstract] [Full Text] [Related]
8. Myasthenia gravis: monoclonal antihuman acetylcholine receptor antibodies used to analyze antibody specificities and responses to treatment.
Whiting PJ; Vincent A; Newsom-Davis J
Neurology; 1986 May; 36(5):612-7. PubMed ID: 3703260
[TBL] [Abstract][Full Text] [Related]
9. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
[TBL] [Abstract][Full Text] [Related]
10. MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG.
Ohta K; Shigemoto K; Kubo S; Maruyama N; Abe Y; Ueda N; Ohta M
Neurology; 2004 Jun; 62(11):2132-3. PubMed ID: 15184636
[No Abstract] [Full Text] [Related]
11. Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis.
Ohta M; Itoh M; Hara H; Itoh N; Nishitani H; Hayashi K; Ohta K
Clin Chim Acta; 1991 Sep; 201(3):201-5. PubMed ID: 1756593
[TBL] [Abstract][Full Text] [Related]
12. Anti-acetylcholine receptor antibodies.
Vincent A; Newsom Davis J
J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):590-600. PubMed ID: 7400823
[TBL] [Abstract][Full Text] [Related]
13. Myasthenia gravis and autoantibodies.
Nishitani H
Jpn J Med; 1988 May; 27(2):228-9. PubMed ID: 3418994
[No Abstract] [Full Text] [Related]
14. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
[TBL] [Abstract][Full Text] [Related]
15. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
[TBL] [Abstract][Full Text] [Related]
16. Acetylcholine receptor epitopes on epithelial cells of thymoma in myasthenia gravis.
Kirchner T; Hoppe F; Müller-Hermelink HK; Schalke B; Tzartos S
Lancet; 1987 Jan; 1(8526):218. PubMed ID: 2433555
[No Abstract] [Full Text] [Related]
17. [Myasthenia gravis. Prototype of an anti-receptor autoaggression disease (author's transl)].
Hohlfeld R; Wekerle H
MMW Munch Med Wochenschr; 1981 Jul; 123(31):1207-11. PubMed ID: 6790965
[TBL] [Abstract][Full Text] [Related]
18. Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells.
Gilhus NE; Willcox N; Harcourt G; Nagvekar N; Beeson D; Vincent A; Newsom-Davis J
J Neuroimmunol; 1995 Jan; 56(1):65-76. PubMed ID: 7822483
[TBL] [Abstract][Full Text] [Related]
19. Cellular response to human acetylcholine receptor in patients with myasthenia gravis.
McQuillen DP; Koethe SM; McQuillen MP
J Neuroimmunol; 1983 Aug; 5(1):59-65. PubMed ID: 6603473
[TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic autoimmunity in thymus tumors.
Marx A; Schultz A; Wilisch A; Helmreich M; Nenninger R; Müller-Hermelink HK
Dev Immunol; 1998; 6(1-2):129-40. PubMed ID: 9716914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
